| Session
1 -
Opening Session
Keynote address:
Advances in surgery
Lars Holmberg
Keynote address:
Advances in medical oncology
Nancy E Davidson
Session 3 -
Management of the Axilla
Results of
the Swedish trial in sentinel node biopsy
Lars Holmberg
Update on the SNAC
Trial
Neil R Wetzig
Will sentinel node biopsy end
the debate about routine axillary clearance? - The NO case
Andrew Spillane
Will sentinel node
biopsy end the debate about routine axillary clearance? - The YES
case
Boon Chua
Session 5 -
Research Issues
Role of ovarian
ablation
Nancy E Davidson
New receptors
for diagnosis - Improving cancer diagnosis: Detection of preneoplasia
in breast epithelial cells
Julian A Barden, Margaret Pooley, Michael D Slater
Targeting molecular
mechanisms in cancer
Rosemary L Balleine
Session 7 -
The Place of Mastectomy
Incidence of
local recurrence after complete local excision (CLE)
Lars Holmberg
RACS Breast
Audit
Peter Malycha, Sarah Tyson
Advances in
breast reconstruction
Rod Cooter
The role of
post-mastectomy radiotherapy
Michael A Izard
Poster
Presentation Abstracts
Treatment
implications of a positive sentinel lymph node biopsy in early breast
cancer
B Chua, O Ung, R Taylor, M Bilous,
E Salisbury, J Boyages
Treatment
of the axilla in early breast cancer - past, present and future
B Chua, O Ung, J Boyages
Frequency
and predictors of axillary lymph node (ALN) metastases in early
breast carcinoma (EBC)
B Chua, O Ung, R Taylor, J Boyages
A model for
consumer-scientist collaboration in clinical trials research
K Finch, J Cockwill and L Brans
Nodal extracapsular
extension (ECE) may be the strongest independent lymphoedema predictor
after nodal radiotherapy for breast cancer
P Graham, R Jagavkar, L Browne, L O'Brien
Active smoking
history does not significantly influence overall survival or patterns
of relapse in a mature cohort of 405 breast cancer patients
P Graham
Accuracy
of combined clinical and ultrasound examination in very young women
with breast cancer
N Houssami & S Zadelis
The influence
of 'palpability' on the sensitivity of ultrasound & mammography
in women with symptoms
N Houssami, S Ciatto, L Irwig, JM Simpson, P Macaskill
Triple sensitivity
test in young women
N Houssami, L Irwig
Benign appearing
breast lesions found incidentally on ultrasound examination
N Houssami, S Zadelis , A Barratt |
Session 2
-
Genetics
Breast cancer
genetics
Judy Kirk
Clinico-pathologic
characteristics and clinical management of women with BRCA1 and
BRCA2 associated breast cancer
Michael Friedlander
Counselling in hereditary breast cancer
Kathy Tucker
Session 4 -
Applied Chemotherapy
Treatment of
metastatic disease
Nancy E Davidson
Significance of HER-2-neu
David J Grimes
NHMRC Clinical Practice
Guidelines for the treatment of Advanced Breast Cancer
Frances Boyle
Session 6 -
Tumour Risk Management
Risk of invasive
cancer after DCIS and LCIS
Lars Holmberg
Molecular biology
and the selection of hormonal treatment
Stephen Birrell
The St. Gallen
classification for patients with node-negative breast cancer - Does
it really work?
J Boyages, B Chua, R Taylor, M Bilous, E Salisbury, N Wilcken,
O Ung
Session 8 -
Current Controversies
Current issues
in mammographic screening
Mary T Rickard
Current challenges
in diagnostic breast pathology
Michael Bilous
Why do some
breast cancers present at an advanced stage in women in Australia?
Anne Kricker
Hormonal
replacement therapy after breast cancer -
Is it safe? (HABITS)
Lars Holmberg
Current controversies in
medical oncology
Nancy E Davidson
|
